SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-167489
Filing Date
2024-06-25
Accepted
2024-06-25 08:01:01
Documents
13
Period of Report
2024-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d839417d8k.htm   iXBRL 8-K 24051
  Complete submission text file 0001193125-24-167489.txt   142440

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20240623.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20240623_lab.xml EX-101.LAB 17168
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20240623_pre.xml EX-101.PRE 10793
17 EXTRACTED XBRL INSTANCE DOCUMENT d839417d8k_htm.xml XML 3613
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 241066182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)